Genmab — Maj 2021

[Helge_LarsenPI-redaktør]

Sorry. I've been busy all day with podcasts and video production. Darzalex April was $ 298M. Increase of just over 10% as there were 2 working days less compared to March.

[E_L]

But I think we have see all the epco data we will get in the EHA abstract this week tbh

[E_L]

thanks Helge; solid number; next month over

300

[GeorgeBest]

Okay E L. I just had this comment in mind from Jan, and it was related to ASCO: „ Let us start with our own product candidates. There will be an important presentation on epco data from the initial Phase I/II study. This presentation will highlight the promise and success of our DuoBody platform..“

[E_L]

i know, but the EHA and ASCO abstract had to be sent in around the same time, so the data can not be (much) different i think. They may elaborate with a bit of an update again in June, during the presentation though?

[Darvin]

Tak Helge. Mindre rettelse - 6% stigning ift marts, da der var en arbejdsdag mindre. Fortsat rigtig fint. Væsentligt bedre 4 mdr i 21 end de første 4 i 20

[E_L]

and by the way that eha data was very good, and will get more attention at ASCO

[Darvin]

Ikke - 6 men +6

[E_L]

yes, last year apr and may was slow, wasn't it, great % rise
over last year this month

[E_L]

didn't check but could be an all time high % change over last year...

[Bulder]

asco abstracts are released at 23.00 tonight

[GeorgeBest]

Thanks E L & Bulder

[E_L]

good luck Helge, looking forward to the summaries tomorrow morning

[Darvin]

Rigth EL 17.10 65% increase compared to april 2020 and 46,5% increase compared to først 4 months 2020. Excellent

[Helge_LarsenPI-redaktør]

E L I play football tonight with the young people in the club. Must therefore, as usual, go to bed early and get up late tomorrow.

[E_L]

a much better way to spend your time lol, enjoy!

[Bulder]

Well, glofi har 3 pts ud af 52 med CRS grade 3. Epco har ingen over grade 2. Glofi: CRS was mostly(!) manageable.

[peter12]

Media release https://ir.genmab.com/news-releases/news-release-details/genmab-announces-abstracts-evaluating-products-pipeline

[Bulder]

Responser synes jeg er svært at udlede, men epco nævner 55% CR og glofi nævner 57,1% CMR i dlbcl. Altså næsten det samme. Med alle forbehold.

[Helge_LarsenPI-redaktør]

Genmab vil præsentere data til kommende konferencer - GENT
https://www.proinvestor.com/investornyt/675234/genmab-vil-praesentere-data-til-kommende-konferencer-gent